PPARA and hepatocellular carcinoma: Pathway enrichment analysis revealed that the drug-metabolizing cytochrome P450 pathway, tyrosine metabolism, PPAR signaling pathway, DNA-dependent ATPase activity, and other drug therapeutic-related signaling pathways were related to SMC family members in HCC.